At the risk of harping on the obvious, if our destiny as small...

At the risk of harping on the obvious, if our destiny as small shareholders is as you suggest then we will have to just harden up and deal with it. However IMO there are many chapters yet to be written on the long journey of MSB which could include multiple science divisions - active global marketing or global research centres or active global specialist partnerships for heart, spinal, gut health etc, too many to mention.

A full takeover bid if it were to occur would dramatically signal to the world including you, our board, major and minor shareholders, and all entities thinking to move into the regenerative space that time is running out, and that this is the notional starting point to making a deal of any kind, including partnership, with MSB.

I hope you get that - especially for the sake of the thousands of shareholders who are currently underwater on their small investment, and might not be that fussed about the ultimate long term reward if it were to occur (some have waited 10 years already) but would be looking good at maybe $5.

Perhaps the biggest advantage is that we holders never have to hear again from the down ramping commentators on Hot Copper who cannot stomach MSB as an investment because it is impossible (they say) to put a real value on the business.